Inomax Articles
NicOx files for European approval of naproxcinod in OA indication
23 December 2009
NicOx raises 30 million-euro in private placements with backing from French govt’s FSI fund; files naproxcinod with FDA
19 November 2009
Cordex and BGM team up on Ph II HF trial
9 April 2009
NicOx enters Ph I with Lipitor competitor
23 March 2009
NicOx "on the brink" of becoming a drugmaker
9 March 2009
NicOx' shares up 19% on naproxcinod data
1 December 2008
NicOx shares up 44% on strong late-stage data
10 November 2008
Aires licenses NO prodrug from US NIH
27 October 2008
NicOx in manufacturing deal with Capsugel
29 September 2008
NeurAxon's NXN-188 shows pain relief in migraine with aura
15 September 2008
NicOx and Pfizer in talks over PF-03187207 rights
1 September 2008
Strong 52-week safety data for naproxcinod
4 August 2008
NicOx complete enrollment in Ph III OA trial
28 July 2008
Watermelon NO boost, similar to Viagra
14 July 2008
Cherries may offer natural arthritis relief
19 May 2008
Nitrate-rich foods protect stomach ulcers
19 May 2008
Pfizer drops mid-stage NicOx glaucoma drug
12 May 2008
NicOx in deal for commercial production of naproxcinod
24 March 2008
Review study suggests NSAIDs, including aspirin, may cut risk of developing breast cancer 20%
17 March 2008
NicOx initiates two ABPM naproxcinod trials
10 March 2008
Beetroot juice "can beat blood pressure"
18 February 2008
Pfizer extends research phase of NicOx eye accord
14 January 2008
NicOx enrolls Ph III naproxcinod trial
24 December 2007
Naproxcinod superior to naproxen in Ph III OA trial
19 November 2007
Strong ABPM data for naproxcinod vs naproxen
12 November 2007
NicOx' 9-month 2007 revenue grows 175%
5 November 2007
AlphaRx selects ARX82 for advanced preclin development
24 September 2007
Positive Ph I data for NXN-188
20 August 2007
Merck & Co pays NicOx SA $6.8M milestone
23 July 2007
NicOx initiates final Ph III naproxcinod trial
9 July 2007
Kalypsys starts 2nd Ph I trial of pain drug
30 April 2007
NicOx to receive 1M euros from Pfizer deal
2 April 2007
Cocoa flavanols may help cognitive health
26 February 2007
NicOx/Pfizer's glaucoma drug yields strong preclinical data
19 February 2007
NicOx gets $6.5M under Merck & Co R&D accord
29 January 2007
French biotech fares better in 2006
15 January 2007
Aerovance's Aerovant performs well in Phase IIa asthma trial
15 January 2007
Strong animal data on NicOx' blood pressure drug
20 November 2006
Positive Ph III for NicOx' naproxcinod
6 November 2006
NicOx reports encouraging top-line Ph III data for naproxcinod
6 November 2006
NicOx' NCX 6560 moves into preclinical development
11 September 2006
NicOx completes enrollment in naproxcinod ABPM trial
14 August 2006
NicOx partner Topigen starts Ph II with TPI-1020
29 May 2006
Merck & Co pays NicOx $11.2M in global deal
27 March 2006
New cocoa flavanol study provides evidence for cardiovascular health
20 February 2006
NitroMed and Boston Sci complete R&D deal
9 January 2006
NicOx's HCT1026 slows bone loss in osteopenia
18 July 2005
Mylan's nebivolol sees good results
30 May 2005
deCODE starts dosing in asthma trial
23 May 2005
European Union invests 10.7 million euros in EICOSANOX
21 February 2005
NicOx gains 26M euros from private placement
11 October 2004
Global analgesic mkt "to nearly double by 2010"
4 October 2004
NicOx and Pfizer enter collaboration
6 September 2004
Mylan's nebivolol on track in USA
12 July 2004
NicOx' HCT 1026 shows promise in AD
19 April 2004
Positive data for NicOx' NCX-4016
22 September 2003
Cellegy issued patent for female sexual dysfunction therapy method
8 September 2003
First launch, in Canada, for AstraZeneca's superstatin Crestor
24 February 2003
AstraZeneca/NicOx' painkiller: mixed data
24 February 2003
NicOx and Biolipox expand research collaboration
3 February 2003
NicOx' NO-donating salt a potential asthma drug
15 July 2002
Avandia may impact heart risk factors
24 June 2002
NicOx NO-aspirin clears Phase I, starts Phase II in PAD
22 April 2002
Strakan launches home-grown acne drug Zindaclin in UK
25 March 2002
Cellegy acquires Vaxis Therapeutics
30 November 2001
NicOx reports new data on NO-aspirin drug in insulin resistance
22 November 2001
First inhaled nitric oxide therapy approved in EU
8 August 2001
Losses deepen at France's NicOx
31 July 2001
Medinox' NOX-100 starts sepsis study
11 July 2001
NicOx reports results with NO-paracetamol
27 June 2001
NicOx and Biolipox sign R&D pact
26 June 2001
France's NicOx raises 55.4 million euros
24 May 2001
NicOx looking to raise 64 million euros
10 May 2001
NicOx reports progress with topical anti-inflammtory
30 November 2000
Medinox, Fuso to develop sepsis drug
10 May 2000
"Significant progress" for NicOx in 1999
20 March 2000
NicOx starts trials of NO-aspirin
25 February 2000
INO Therapeutics gets approvable letter for INOmax
24 November 1999
NitroMed acquires BiDil NDA for CHF therapy
22 September 1999
UK launch for nebivolol and Menarini
30 March 1999
Cyclosporine patented for use CNS disorders
12 March 1999
AGA to file first selective pulmonary vasodilator
10 March 1999
NicOx Looks For Partners To Develop Nitric Oxide Donors
27 October 1998
The Emerging Role Of Anticytokine Therapy
1 October 1998
Evolution In Migraine Therapy; New Triptans, And Beyond
10 September 1998
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
